Brief: Allergy Therapeutics Sees H2 Revenue At £21.6M
22/07/2024 07:14
July 22 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS - TRADING UPDATE FOR THE YEAR ENDED
30
JUNE 2024
* ALLERGY THERAPEUTICS PLC - H2 REVENUE EXPECTED AT £21.6M
Source text for Eikon: ID:nRSV1697Xa
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman